Milestone Scientific (NYSE:MLSS – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Milestone Scientific and IceCure Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Milestone Scientific | 0 | 0 | 1 | 0 | 3.00 |
| IceCure Medical | 1 | 1 | 3 | 0 | 2.40 |
Milestone Scientific presently has a consensus target price of $1.00, indicating a potential upside of 103.67%. IceCure Medical has a consensus target price of $62.70, indicating a potential upside of 1,709.00%. Given IceCure Medical’s higher probable upside, analysts plainly believe IceCure Medical is more favorable than Milestone Scientific.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Milestone Scientific | $8.90 million | 4.88 | -$6.93 million | ($0.05) | -9.82 |
| IceCure Medical | $3.38 million | 3.52 | -$15.06 million | ($7.21) | -0.48 |
Milestone Scientific has higher revenue and earnings than IceCure Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Milestone Scientific has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500.
Profitability
This table compares Milestone Scientific and IceCure Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Milestone Scientific | -52.01% | -60.26% | -40.23% |
| IceCure Medical | -441.60% | -211.73% | -119.13% |
Insider and Institutional Ownership
5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by company insiders. Comparatively, 2.4% of IceCure Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
Milestone Scientific beats IceCure Medical on 11 of the 14 factors compared between the two stocks.
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
